Skip Nav Destination
Article navigation
Education|
July 1984
Effect of Age, Gender, and Obesity on Midazolam Kinetics
David J. Greenblatt, M.D.;
David J. Greenblatt, M.D.
* Chief, Division of Clinical Pharmacology; Professor of Psychiatry and Associate Professor of Medicine, Tufts University School of Medicine and New England Medical Center.
† Associate Chief, Division of Clinical Pharmacology; Assistant Professor of Psychiatry and Medicine, Tufts University School of Medicine and New England Medical Center. Present address: Section on Hypertension/Clinical Pharmacology, Baylor College of Medicine, Houston, Texas.
‡ Director of Analytical Laboratory, Division of Clinical Pharmacology, Tufts University School of Medicine and New England Medical Center.
§ Assistant Professor of Psychiatry, Tufts University School of Medicine and New England Medical Center.
¶ Department of Clinical Pharmacology, Hoffmann-LaRoche, Inc., Nutley, New Jersey.
** Professor and Chairman, Department of Psychiatry, Tufts University School of Medicine and New England Medical Center.
† Associate Chief, Division of Clinical Pharmacology; Assistant Professor of Psychiatry and Medicine, Tufts University School of Medicine and New England Medical Center. Present address: Section on Hypertension/Clinical Pharmacology, Baylor College of Medicine, Houston, Texas.
‡ Director of Analytical Laboratory, Division of Clinical Pharmacology, Tufts University School of Medicine and New England Medical Center.
§ Assistant Professor of Psychiatry, Tufts University School of Medicine and New England Medical Center.
¶ Department of Clinical Pharmacology, Hoffmann-LaRoche, Inc., Nutley, New Jersey.
** Professor and Chairman, Department of Psychiatry, Tufts University School of Medicine and New England Medical Center.
Search for other works by this author on:
Darrell R. Abernethy, M.D., Ph.D.;
Darrell R. Abernethy, M.D., Ph.D.
* Chief, Division of Clinical Pharmacology; Professor of Psychiatry and Associate Professor of Medicine, Tufts University School of Medicine and New England Medical Center.
† Associate Chief, Division of Clinical Pharmacology; Assistant Professor of Psychiatry and Medicine, Tufts University School of Medicine and New England Medical Center. Present address: Section on Hypertension/Clinical Pharmacology, Baylor College of Medicine, Houston, Texas.
‡ Director of Analytical Laboratory, Division of Clinical Pharmacology, Tufts University School of Medicine and New England Medical Center.
§ Assistant Professor of Psychiatry, Tufts University School of Medicine and New England Medical Center.
¶ Department of Clinical Pharmacology, Hoffmann-LaRoche, Inc., Nutley, New Jersey.
** Professor and Chairman, Department of Psychiatry, Tufts University School of Medicine and New England Medical Center.
† Associate Chief, Division of Clinical Pharmacology; Assistant Professor of Psychiatry and Medicine, Tufts University School of Medicine and New England Medical Center. Present address: Section on Hypertension/Clinical Pharmacology, Baylor College of Medicine, Houston, Texas.
‡ Director of Analytical Laboratory, Division of Clinical Pharmacology, Tufts University School of Medicine and New England Medical Center.
§ Assistant Professor of Psychiatry, Tufts University School of Medicine and New England Medical Center.
¶ Department of Clinical Pharmacology, Hoffmann-LaRoche, Inc., Nutley, New Jersey.
** Professor and Chairman, Department of Psychiatry, Tufts University School of Medicine and New England Medical Center.
Search for other works by this author on:
Ann Locniskar, B.S.;
Ann Locniskar, B.S.
* Chief, Division of Clinical Pharmacology; Professor of Psychiatry and Associate Professor of Medicine, Tufts University School of Medicine and New England Medical Center.
† Associate Chief, Division of Clinical Pharmacology; Assistant Professor of Psychiatry and Medicine, Tufts University School of Medicine and New England Medical Center. Present address: Section on Hypertension/Clinical Pharmacology, Baylor College of Medicine, Houston, Texas.
‡ Director of Analytical Laboratory, Division of Clinical Pharmacology, Tufts University School of Medicine and New England Medical Center.
§ Assistant Professor of Psychiatry, Tufts University School of Medicine and New England Medical Center.
¶ Department of Clinical Pharmacology, Hoffmann-LaRoche, Inc., Nutley, New Jersey.
** Professor and Chairman, Department of Psychiatry, Tufts University School of Medicine and New England Medical Center.
† Associate Chief, Division of Clinical Pharmacology; Assistant Professor of Psychiatry and Medicine, Tufts University School of Medicine and New England Medical Center. Present address: Section on Hypertension/Clinical Pharmacology, Baylor College of Medicine, Houston, Texas.
‡ Director of Analytical Laboratory, Division of Clinical Pharmacology, Tufts University School of Medicine and New England Medical Center.
§ Assistant Professor of Psychiatry, Tufts University School of Medicine and New England Medical Center.
¶ Department of Clinical Pharmacology, Hoffmann-LaRoche, Inc., Nutley, New Jersey.
** Professor and Chairman, Department of Psychiatry, Tufts University School of Medicine and New England Medical Center.
Search for other works by this author on:
Jerold S. Harmatz, B.A.;
Jerold S. Harmatz, B.A.
* Chief, Division of Clinical Pharmacology; Professor of Psychiatry and Associate Professor of Medicine, Tufts University School of Medicine and New England Medical Center.
† Associate Chief, Division of Clinical Pharmacology; Assistant Professor of Psychiatry and Medicine, Tufts University School of Medicine and New England Medical Center. Present address: Section on Hypertension/Clinical Pharmacology, Baylor College of Medicine, Houston, Texas.
‡ Director of Analytical Laboratory, Division of Clinical Pharmacology, Tufts University School of Medicine and New England Medical Center.
§ Assistant Professor of Psychiatry, Tufts University School of Medicine and New England Medical Center.
¶ Department of Clinical Pharmacology, Hoffmann-LaRoche, Inc., Nutley, New Jersey.
** Professor and Chairman, Department of Psychiatry, Tufts University School of Medicine and New England Medical Center.
† Associate Chief, Division of Clinical Pharmacology; Assistant Professor of Psychiatry and Medicine, Tufts University School of Medicine and New England Medical Center. Present address: Section on Hypertension/Clinical Pharmacology, Baylor College of Medicine, Houston, Texas.
‡ Director of Analytical Laboratory, Division of Clinical Pharmacology, Tufts University School of Medicine and New England Medical Center.
§ Assistant Professor of Psychiatry, Tufts University School of Medicine and New England Medical Center.
¶ Department of Clinical Pharmacology, Hoffmann-LaRoche, Inc., Nutley, New Jersey.
** Professor and Chairman, Department of Psychiatry, Tufts University School of Medicine and New England Medical Center.
Search for other works by this author on:
Raul A. Limjuco, M.D.;
Raul A. Limjuco, M.D.
* Chief, Division of Clinical Pharmacology; Professor of Psychiatry and Associate Professor of Medicine, Tufts University School of Medicine and New England Medical Center.
† Associate Chief, Division of Clinical Pharmacology; Assistant Professor of Psychiatry and Medicine, Tufts University School of Medicine and New England Medical Center. Present address: Section on Hypertension/Clinical Pharmacology, Baylor College of Medicine, Houston, Texas.
‡ Director of Analytical Laboratory, Division of Clinical Pharmacology, Tufts University School of Medicine and New England Medical Center.
§ Assistant Professor of Psychiatry, Tufts University School of Medicine and New England Medical Center.
¶ Department of Clinical Pharmacology, Hoffmann-LaRoche, Inc., Nutley, New Jersey.
** Professor and Chairman, Department of Psychiatry, Tufts University School of Medicine and New England Medical Center.
† Associate Chief, Division of Clinical Pharmacology; Assistant Professor of Psychiatry and Medicine, Tufts University School of Medicine and New England Medical Center. Present address: Section on Hypertension/Clinical Pharmacology, Baylor College of Medicine, Houston, Texas.
‡ Director of Analytical Laboratory, Division of Clinical Pharmacology, Tufts University School of Medicine and New England Medical Center.
§ Assistant Professor of Psychiatry, Tufts University School of Medicine and New England Medical Center.
¶ Department of Clinical Pharmacology, Hoffmann-LaRoche, Inc., Nutley, New Jersey.
** Professor and Chairman, Department of Psychiatry, Tufts University School of Medicine and New England Medical Center.
Search for other works by this author on:
Richard I. Shader, M.D.
Richard I. Shader, M.D.
* Chief, Division of Clinical Pharmacology; Professor of Psychiatry and Associate Professor of Medicine, Tufts University School of Medicine and New England Medical Center.
† Associate Chief, Division of Clinical Pharmacology; Assistant Professor of Psychiatry and Medicine, Tufts University School of Medicine and New England Medical Center. Present address: Section on Hypertension/Clinical Pharmacology, Baylor College of Medicine, Houston, Texas.
‡ Director of Analytical Laboratory, Division of Clinical Pharmacology, Tufts University School of Medicine and New England Medical Center.
§ Assistant Professor of Psychiatry, Tufts University School of Medicine and New England Medical Center.
¶ Department of Clinical Pharmacology, Hoffmann-LaRoche, Inc., Nutley, New Jersey.
** Professor and Chairman, Department of Psychiatry, Tufts University School of Medicine and New England Medical Center.
† Associate Chief, Division of Clinical Pharmacology; Assistant Professor of Psychiatry and Medicine, Tufts University School of Medicine and New England Medical Center. Present address: Section on Hypertension/Clinical Pharmacology, Baylor College of Medicine, Houston, Texas.
‡ Director of Analytical Laboratory, Division of Clinical Pharmacology, Tufts University School of Medicine and New England Medical Center.
§ Assistant Professor of Psychiatry, Tufts University School of Medicine and New England Medical Center.
¶ Department of Clinical Pharmacology, Hoffmann-LaRoche, Inc., Nutley, New Jersey.
** Professor and Chairman, Department of Psychiatry, Tufts University School of Medicine and New England Medical Center.
Search for other works by this author on:
Anesthesiology July 1984, Vol. 61, 27–35.
Citation
David J. Greenblatt, Darrell R. Abernethy, Ann Locniskar, Jerold S. Harmatz, Raul A. Limjuco, Richard I. Shader; Effect of Age, Gender, and Obesity on Midazolam Kinetics . Anesthesiology 1984; 61:27–35 doi: https://doi.org/10.1097/00000542-198407000-00006
Download citation file:
400
Views
Citing articles via
Most Viewed
Related Articles
Gender Differences in Anesthesiologists' Annual Incomes
Anesthesiology (April 2007)
Influence of Age and Gender on the Pharmacokinetics and Pharmacodynamics of Remifentanil: I. Model Development
Anesthesiology (January 1997)
Regional and Gender Differences and Trends in the Anesthesiologist Workforce
Anesthesiology (November 2015)
Gender Affects Report of Pain and Function after Arthroscopic Anterior Cruciate Ligament Reconstruction
Anesthesiology (September 2000)
Gender and Post–Dural Puncture Headache
Anesthesiology (September 2006)